European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic …
J Dawson, Y Béjot, LM Christensen… - European stroke …, 2022 - journals.sagepub.com
Recurrent stroke affects 9% to 15% of people within 1 year. This European Stroke
Organisation (ESO) guideline provides evidence-based recommendations on …
Organisation (ESO) guideline provides evidence-based recommendations on …
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High …
P Urban, R Mehran, R Colleran, DJ Angiolillo… - Circulation, 2019 - Am Heart Assoc
Identification and management of patients at high bleeding risk undergoing percutaneous
coronary intervention are of major importance, but a lack of standardization in defining this …
coronary intervention are of major importance, but a lack of standardization in defining this …
2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing …
The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …
decision pathways, health policy statements, appropriate use criteria) to provide members …
[PDF][PDF] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
P Kirchhof, S Benussi, D Kotecha… - Polish Heart …, 2016 - journals.viamedica.pl
Komisję ESC ds. Wytycznych Postępowania nadzoruje i koordynuje przygotowywanie
nowych wytycznych i stanowisk przez grupy robocze i inne grupy ekspertów. Komitet jest …
nowych wytycznych i stanowisk przez grupy robocze i inne grupy ekspertów. Komitet jest …
[HTML][HTML] Prevention of bleeding in patients with atrial fibrillation undergoing PCI
Background In patients with atrial fibrillation undergoing percutaneous coronary intervention
(PCI) with placement of stents, standard anticoagulation with a vitamin K antagonist plus …
(PCI) with placement of stents, standard anticoagulation with a vitamin K antagonist plus …
Atualização da diretriz de ressuscitação cardiopulmonar e cuidados cardiovasculares de emergência da Sociedade Brasileira de Cardiologia-2019
C Bernoche, S Timerman, TF Polastri… - Arquivos brasileiros de …, 2019 - SciELO Brasil
A doença cardíaca isquêmica, principal determinante da PCR, continua liderando as
causas de morte no mundo, e no Brasil não é diferente. 1, 2 Em 2013, nos Estados Unidos …
causas de morte no mundo, e no Brasil não é diferente. 1, 2 Em 2013, nos Estados Unidos …
[PDF][PDF] 2014 ESC/EACTS Guidelines on myocardial revascularization
Zachęca się pracowników opieki zdrowotnej, aby w pełni uwzględniali te wytyczne
ESC/EACTS, gdy dokonują oceny klinicznej, a także kiedy określają i realizują medyczne …
ESC/EACTS, gdy dokonują oceny klinicznej, a także kiedy określają i realizują medyczne …
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
Advances in antithrombotic therapy, along with an early invasive strategy, have reduced the
incidence of recurrent ischemic events and death in patients with acute coronary syndromes …
incidence of recurrent ischemic events and death in patients with acute coronary syndromes …
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the …
Authors/Task Force Members, CW Hamm… - European heart …, 2011 - academic.oup.com
ESC Guidelines 3002 recommendations. To implement the guidelines, condensed pocket
guidelines versions, summary slides, booklets with essential messages, and an electronic …
guidelines versions, summary slides, booklets with essential messages, and an electronic …
[HTML][HTML] Rivaroxaban in patients with a recent acute coronary syndrome
JL Mega, E Braunwald, SD Wiviott… - … England Journal of …, 2012 - Mass Medical Soc
Background Acute coronary syndromes arise from coronary atherosclerosis with
superimposed thrombosis. Since factor Xa plays a central role in thrombosis, the inhibition of …
superimposed thrombosis. Since factor Xa plays a central role in thrombosis, the inhibition of …